Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimit Girish Raghav

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Topics in Behavioral Neurosciences|October 19, 2016
Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and ManTorbjörn U C Järbe, Jimit Girish Raghav
Bioorganic & Medicinal Chemistry|August 21, 2018
Oximes short-acting CB1 receptor agonistsMichael S Malamas, Jimit Girish Raghav, Xiaoyu Ma, et al.
Psychopharmacology|November 24, 2023
The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female miceJimit Girish Raghav, Hritik Kumar, Lipin Ji, et al.
Journal of Medicinal Chemistry|July 2, 2016
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic AnaloguesShashank Kulkarni, Spyros P Nikas, Rishi Sharma, et al.
Journal of Medicinal Chemistry|November 30, 2013
Controlled-deactivation cannabinergic ligandsRishi Sharma, Spyros P Nikas, Carol A Paronis, et al.
Journal of Medicinal Chemistry|December 4, 2014
Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinolsSpyros P Nikas, Rishi Sharma, Carol A Paronis, et al.
Journal of Medicinal Chemistry|March 24, 2021
Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent AgonistsShan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Topics in Behavioral Neurosciences|October 19, 2016
Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and ManTorbjörn U C Järbe, Jimit Girish Raghav
Bioorganic & Medicinal Chemistry|August 21, 2018
Oximes short-acting CB1 receptor agonistsMichael S Malamas, Jimit Girish Raghav, Xiaoyu Ma, et al.
Psychopharmacology|November 24, 2023
The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female miceJimit Girish Raghav, Hritik Kumar, Lipin Ji, et al.
Journal of Medicinal Chemistry|July 2, 2016
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic AnaloguesShashank Kulkarni, Spyros P Nikas, Rishi Sharma, et al.
Journal of Medicinal Chemistry|November 30, 2013
Controlled-deactivation cannabinergic ligandsRishi Sharma, Spyros P Nikas, Carol A Paronis, et al.
Journal of Medicinal Chemistry|December 4, 2014
Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinolsSpyros P Nikas, Rishi Sharma, Carol A Paronis, et al.
Journal of Medicinal Chemistry|March 24, 2021
Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent AgonistsShan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, et al.
Pageof 1